What is Replimune Group's investment purchases?

Replimune Group (REPL) reported investment purchases of $26.51M in Q4 2025.

How has Replimune Group's investment purchases changed year-over-year?

Replimune Group's investment purchases decreased by 80.7% year-over-year, from $137.02M to $26.51M.

What is the long-term trend for Replimune Group's investment purchases?

Over 3 years (2022 to 2025), Replimune Group's investment purchases has grown at a 16.4% compound annual growth rate (CAGR), from $255.72M to $403.59M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Replimune Group REPL Investment Purchases

Investment Purchases at other companies

CG OncologyCGON

$587.39M+62.3%

Relay Therapeutics, Inc.RLAY

$50.9M+132%

IDEAYA Biosciences, Inc.IDYA

$42.61M-59.5%

ImmunityBio, Inc.IBRX

$139.09M+138,993%

Summit TherapeuticsSMMT

$177.29M—

Nektar TherapeuticsNKTR

$452.25M+1,714%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+28.6%

Enterprise value$885.15M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's investment purchases?: Replimune Group (REPL) reported investment purchases of $26.51M in Q4 2025.
How has Replimune Group's investment purchases changed year-over-year?: Replimune Group's investment purchases decreased by 80.7% year-over-year, from $137.02M to $26.51M.
What is the long-term trend for Replimune Group's investment purchases?: Over 3 years (2022 to 2025), Replimune Group's investment purchases has grown at a 16.4% compound annual growth rate (CAGR), from $255.72M to $403.59M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.